Available soon:   Digital agency's social media & community optimizer.

Digital Rectal Examination Prostate Specific Antigen : The Studies

These Digital Rectal Examination Prostate Specific Antigen studies, according to our research, make excellent supplementary materials.

Digital Rectal Exam and Prostate-Specific Antigen Tests in Diagnosing Prostate Cancer

An analysis about the accuracy of digital rectal examination and prostate-specific antigen tests in diagnosing prostate cancer has been conducted. The study found that the tests were accurate in diagnosing prostate cancer, but had lower accuracy in predicting the progress of the disease.

Digital Rectal Examination Prostate Specific Antigen : The Studies

Cancers Detected by Prostate Cancer Detection Program in Asymptomatic Men

An analysis about 1,940 asymptomatic men who were included in a prostate cancer detection program included digital rectal exam (DRE), prostate?specific antigen (PSA), and transrectal ultrasound (TRUS). Out of these 1,940 men, seventy-four cancers were found which is 84%. From these cancers, the study found that eighty-eight percent had clinically organ confined tumors.

Digital Rectal Examination: A valuable tool for diagnosis

A study about the importance of digital rectal examination revealed that there are a number of cases where it can help diagnose diseases and also provide other valuable information. The study found that almost every person has at least one instance where DRE can help them with a possible diagnosis. This is an important skill for the medical professional, as it can help obtain information that would otherwise be difficult or impossible to gather.

The Increase in Prostate Sarcoma Levels after Digital Rectal Examination

A study about rectal examination by primary care internists found an increase in PSA levels following digital rectal examination. The men in the study had no history of surgery, prostatitis, or cancer, so the increase in PSA levels must have been due to something else. The study found that the PSA levels increased from baseline by 3.8 times and by 4.2 times after getting a digital rectal examination.

Different Abnormal Rectal Examination Resulted in Different Episodes of Infection

A journal about the different variants of abnormal Rectal examination revealed that the most consistent abnormality was an enlargement of the presence of suspicious nodules. The second most consistent abnormality was a lobar asymmetry, followed by a positive predictive value of 95%.

The Fingerprint of Prostate Cancer

A review about prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen reveals a unique fingerprint. The study found that the needle position on digital rectal examination (DRE) was more accurate in reporting the presence of prostate cancer than other methods. Furthermore, the procedure yielded better results than prostate specific antigen (PSA) testing for prostate cancer diagnosis in U.S. commercial practices.

The Role of Prostate-Specific antigen in Men 50 Years of Age or Older

An evaluation about the role of prostate-specific antigen (PSA) in men 50 years of age or older found that an increased level was associated with a higher risk of developing prostate cancer.

Screening for prostate cancer using a PSA threshold

A study about PSA screening for prostate cancer within the PSA range versus without prostate cancer showed that for men with PSA levels in the 3.9-4.2 ng/ml range, nearly three out of four were histologically classified as having no cancer, while in those with lower PSA levels, only around 16% of samples were still negative on a Western blot assay. This suggests that using a threshold level of 3 ng/ml may be more accurate in predicting risk than using a lower limit or no test.

Helical CT for Prostate Cancer Evaluation: A Study of Ten and Eleven Percent

A study about 25 patients with prostate cancer who underwent helical CT for evaluation found that in group I (45-72 years old) tumors were found in 10% of patients and in group II (50-65 years old) tumors were found in 11%. In group III, (73-86 years old) tumors were found in no patient.

User Photo
Reviewed & Published by Albert
Submitted by our contributor
Digital Category
Albert is an expert in internet marketing, has unquestionable leadership skills, and is currently the editor of this website's contributors and writer.